Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

PROTECTIVE POISON AT HIGH ALTITUDE: THERAPEUTIC EFFECTS OF ELEVATED ENDOGENOUS CO FROM ADAPTIVE HMOX2 VARIANTS

Award Number: F31HL174120
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 04/01/2025
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

PROTECTIVE POISON AT HIGH ALTITUDE: THERAPEUTIC EFFECTS OF ELEVATED ENDOGENOUS CO FROM ADAPTIVE HMOX2 VARIANTS - Project Summary The key focus of this project is to determine the link between genotype and phenotype in the context of Tibetan adaptation to high altitude and to elucidate the currently unresolved mechanism of action through which Tibetans are conferred protection from pulmonary arterial hypertension. The project’s long-term goal is to further the understanding and use of carbon monoxide releasing molecules (CORMs) in treating pulmonary arterial hypertension. Pulmonary arterial hypertension is a global health concern that is characterized by pulmonary arterial wall thickening, vasoconstriction, and thrombus. Recent investigations of populations residing at high altitude revealed that many Tibetans residing at 4,200 m of altitude are protected from maladaptations to hypoxia relative to other populations resident at comparable high altitudes. Specifically, many Tibetans exhibit lower hemoglobin concentrations and pulmonary arterial pressures as well as elevated levels of nitric oxide. The Simonson lab previously conducted a genome wide selection scan of 31 Tibetan individuals, revealing a strong signal of natural selection in a region of the genome encompassing the gene coding for the constitutively active heme oxygenase isoform 2, HMOX2. In a study of individuals of Tibetan descent, they also determined that Tibetans have higher levels of carboxyhemoglobin than individuals of Han Chinese descent living at similar intermediate altitude. Recent studies demonstrate the therapeutic potential of carbon monoxide and CORMs through regulation of inflammatory and vasoactive responses. Together, these findings and preliminary data point to the hypothesis that adaptive changes in Tibetans are associated with a heme oxygenase-mediated increase in carbon monoxide, which confers protection from pulmonary hypertensive indications arising from chronic hypoxic stress. The design of this project’s research strategy is divided into two parts: (1) bioinformatics and functional analysis of Tibetan genetic variation at HMOX2, (2) biochemical and transcriptomic investigation of CORMs. The project’s focus and goals are aligned with NHLBI’s mission. It aims to investigate newly discovered cardiopulmonary traits in Tibetan populations that are key to their adaptation to high altitude and may provide insight into treating pulmonary arterial hypertension. The project seeks to understand, on the genetic and the cellular level, the mechanism by which carbon monoxide might affect the onset and progression of pulmonary arterial hypertension. Importantly, this project sheds light on differences in health in a unique population and identifies factors at the individual level which will contribute to our knowledge of human response to hypoxia.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $42,596 )
2026	2026	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Lung Diseases Research	000	2	3/24/2026	NON-COMPETING CONTINUATION	$42,596
														Subtotal = $42,596

Issue Date FY: 2025 ( Subtotal = $42,596 )
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Lung Diseases Research	002	1	6/23/2025	NEW	$564
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Lung Diseases Research	001	1	1/23/2025	NEW	$0
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Lung Diseases Research	000	1	1/23/2025	NEW	$42,032
														Subtotal = $42,596

Grand Total All Awards = $85,192

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PROTECTIVE POISON AT HIGH ALTITUDE: THERAPEUTIC EFFECTS OF ELEVATED ENDOGENOUS CO FROM ADAPTIVE HMOX2 VARIANTS

Award Number: F31HL174120

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 04/01/2025

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer